the core of our corporate values
On September 23, Zylox-Tonbridge announced that the Shareholders’ Meeting has approved the H-share incentive trust scheme proposed by its Board of Directors. The trust scheme is intended to give equi...
On August 23, Zylox-Tonbridge (2190.HK) announced that Tonbridge GyclineTM Microcatheter, a product independently developed by Zhuhai Ton-bridge Medical Technology Co., Ltd. (hereinafter referred to a...
Zylox-Tonbridge (2190.HK) recently announced that it has respectively set up an office in Beijing and a R&D center in Shanghai to attract more outstanding industry talents and promote the rapid an...
On July 12, 2021, ZYLOX-TONBRIDGE (2190.HK) announced that the Company has successfully completed enrollment in the PEVENSEY study. The PEVENSEY study is a prospective multicenter randomized controlle...
Zylox-Tonbridge is launching the CYLONE™ Aspiration Catheter in the global market. After introducing the Thrombite™ Clot Retriever Device last year, Zylox-Tonbridge brings again a new option for pat...
On 27th April 2021, the opening ceremony of ZYLOX-TONBRIDGE Industrial Park was held grandly.The park was completed and put into use on April 10th, 2021, covering an area of nearly 23 acres. The park ...